Posts From King World News

Tag Heuer showcases new ambassador with mobile ad

Cara Delevingne for Tag Heuer Swiss watchmaker Tag Heuer is expanding its Cara Delevingne “Don’t Crack Under Pressure” campaign with mobile advertisements on British Vogue. Through reappearing banner ads featuring Ms. Delevingne with a fist and a watch, Tag Heuer is magnifying its new ambassador. Tag Heuer will likely reach young female consumers with this ad placement and ambassador choice. Vogue UK is the pulse of the fashion industry,” said Andrea

Thursday, March 19: Today in Gold and Silver

NEW YORK (TheStreet) — The gold price traded in less than a five dollar price range right up until the Fed spoke.  The price blasted higher from there, but it was obvious from the chart that sellers of last resort were at the ready, with the preliminary rally, along with every subsequent rally meeting the same fate—and the gold price was closed well of its high tick. The low and

Wednesday, March 18: Today in Gold and Silver

NEW YORK (TheStreet) — The gold price traded in a pretty tight range through all of Far East trading on their Tuesday—but once London opened, the price developed its usual negative bias—and around 8:45 a.m. EDT, the HFT boyz and their algorithms stepped in—and the low tick came about 9:20 a.m.—which was another new low for this move down.  From there it blasted higher into the London p.m. gold “fix”—and

Tuesday, March 17: Today in Gold and Silver

NEW YORK (TheStreet) — Monday’s trading session in gold turned out pretty much as expected, with the high tick coming just before the London open—and it was all down hill into the on-the-dot 11:00 a.m. EDT low, which was probably the close of gold trading in London as well.  From there it rallied unsteadily into the close of electronic trading.  This was same trading pattern as we’ve had during the

Saturday, March 14: Today in Gold and Silver

NEW YORK (TheStreet) — As has been the case for three days in a row, the smallish rally in gold in Far East trading met the usual not-for-profit sellers an hour or so before the London open.  The low tick came shortly after 11:00 a.m. EDT in New York.  The gold price rallied quietly from there, before tacking on another quick five bucks in the last hour of trading in

March Madness to the Masters: The Best Time to Sell a House

Filed under: Selling Alamy By Catherine Sherman You've heard it before: List your home early in the year. That way, you'll be ready to close the deal when home sales peak in June. But what exactly does "early in the year" mean? Based on an analysis of supply, demand and sellers' outcomes in the book "Zillow Talk: The New Rules of Real Estate," co-authors Spencer Rascoff and Stan Humphries have

Campaign hopes for Tasmanian tobacco-free generation law

Campaigners for a proposed law to ban tobacco sales to anyone born after 2000 said Thursday they were hopeful the bill will be adopted by an Australian state’s parliament next week. Under the bill, the island of Tasmania would lift the age at which people can legally buy cigarettes — currently 18 — a year at a time to achieve a “tobacco-free generation”. “Tuesday is the vote in the legislative

Exclusive: Despite Hillary Clinton promise, charity did not disclose donors

By Jonathan Allen NEW YORK (Reuters) – In 2008, Hillary Clinton promised Barack Obama, the president-elect, there would be no mystery about who was giving money to her family’s globe-circling charities. She made a pledge to publish all the donors on an annual basis to ease concerns that as secretary of state she could be vulnerable to accusations of foreign influence. At the outset, the Clinton Foundation did indeed publish

FDA panel backs Glaxo asthma drug for adults, not adolescents

(Reuters) – GlaxoSmithKline Plc’s drug to treat chronic breathing problems is safe and effective enough to be approved in adults with asthma, but not adolescents, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday. The panel voted 16-4 that the product, Breo Ellipta, should be approved for once daily treatment of asthma in adults 18 years and older. The FDA is not obliged to follow the